Biotech · Private company
Principia Biopharma, a Sanofi Company
Track this companyFree. Adds Principia Biopharma, a Sanofi Company to your Dealase workspace and tells you when its record changes.
Clinical trials80 recruiting or active
Pipeline programs8From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline8
- RilzabrutinibPhase 3 · Immune ThrombocytopeniaClinicalTrials.gov · fetched Nov 12, 2026
- RilzabrutinibPhase 3 · PemphigusClinicalTrials.gov · fetched Nov 12, 2026
- GlucocorticoidsPhase 2 · Immunoglobulin G4 Related DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- PRN473 (SAR444727)Phase 2 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- rilzabrutinibPhase 2 · Immunoglobulin G4 Related DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- PRN1371Phase 1 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- RilzabrutinibPhase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- RilzabrutinibPhase 1 · Hepatic Function AbnormalClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials8
- Phase 2a Study of the Safety, Tolerability, and Pharmacokinetics of Topically Administered PRN473 (SAR444727) in Patients With Mild to Moderate Atopic DermatitisPHASE2 · COMPLETED · started Aug 13, 2021ClinicalTrials.gov NCT04992546 · fetched Nov 12, 2026
- Pharmacokinetics (PK) of Rilzabrutinib (PRN1008) in Healthy Japanese and Caucasian SubjectsPHASE1 · COMPLETED · started Jan 4, 2021ClinicalTrials.gov NCT06444191 · fetched Nov 12, 2026
- Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)PHASE3 · COMPLETED · started Dec 14, 2020ClinicalTrials.gov NCT04562766 · fetched Nov 12, 2026
- A Study to Evaluate the Effect of Mild and Moderate Hepatic Impairment on the Single-Dose Pharmacokinetics of Rilzabrutinib (PRN1008)PHASE1 · COMPLETED · started Nov 2, 2020ClinicalTrials.gov NCT06444204 · fetched Nov 12, 2026
- Open Label Two-Arm Study to Evaluate Rilzabrutinib in IgG4-Related Disease ParticipantsPHASE2 · COMPLETED · started Aug 22, 2020ClinicalTrials.gov NCT04520451 · fetched Nov 12, 2026
- A Study of PRN1008 in Patients With PemphigusPHASE3 · TERMINATED · started Jan 8, 2019ClinicalTrials.gov NCT03762265 · fetched Nov 12, 2026
- A Study of Rilzabrutinib in Adult Patients With Immune Thrombocytopenia (ITP)PHASE2 · COMPLETED · started Mar 22, 2018ClinicalTrials.gov NCT03395210 · fetched Nov 12, 2026
- A Dose Escalation Study in Solid Tumors and a Dose Expansion Study of PRN1371 in Adult Patients With Metastatic Urothelial CarcinomaPHASE1 · TERMINATED · started Oct 28, 2015ClinicalTrials.gov NCT02608125 · fetched Nov 12, 2026